Terms: = Sarcomas AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Diagnosis
27 results:
1. Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation.
Zhang M; Arjmandi FK; Porembka JH; Seiler SJ; Goudreau SH; Merchant K; Hwang H; Hayes JC
Radiographics; 2023 Nov; 43(11):e230051. PubMed ID: 37856317
[TBL] [Abstract] [Full Text] [Related]
2. Differentiation Between Phyllodes Tumors and Fibroadenomas of Breast Using Mammography-based Machine Learning Methods: A Preliminary Study.
Deng XY; Cao PW; Nan SM; Pan YP; Yu C; Pan T; Dai G
Clin Breast Cancer; 2023 Oct; 23(7):729-736. PubMed ID: 37481337
[TBL] [Abstract] [Full Text] [Related]
3. Differentiation between Phyllodes Tumors and Fibroadenomas through Breast Ultrasound: Deep-Learning Model Outperforms Ultrasound Physicians.
Shi Z; Ma Y; Ma X; Jin A; Zhou J; Li N; Sheng D; Chang C; Chen J; Li J
Sensors (Basel); 2023 May; 23(11):. PubMed ID: 37299826
[TBL] [Abstract] [Full Text] [Related]
4. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
5. "Growing fibroadenoma": Are there clinical and pathological features predicting a phyllodes tumor on surgical excision?
Nam G; Donegan L; Gorbounov M; Hacking S; Wiggins D; Ward R; Yakirevich E; Wang Y
Ann Diagn Pathol; 2023 Feb; 62():152069. PubMed ID: 36527840
[TBL] [Abstract] [Full Text] [Related]
6. Inferior Clinical Outcomes of Pediatric Rhabdomyosarcoma in Thailand: A 16-Year Experience in a Single Tertiary Institution.
Preechawetchakul P; Sripornsawan P; Rajborirug S; Sangkhathat S; Sangsupavanich P; Chotsampancharoen T
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2805-2811. PubMed ID: 36037137
[TBL] [Abstract] [Full Text] [Related]
7. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor.
Cheng CL; Md Nasir ND; Ng GJZ; Chua KWJ; Li Y; Rodrigues J; Thike AA; Heng SY; Koh VCY; Lim JX; Hiew VJN; Shi R; Tan BY; Tay TKY; Ravi S; Ng KH; Oh KSL; Tan PH
Lab Invest; 2022 Mar; 102(3):245-252. PubMed ID: 34819630
[TBL] [Abstract] [Full Text] [Related]
8. Native T1 mapping of the breast in MRI to differentiate fibroadenomas from benign phyllodes tumors: a preliminary study.
Yalcin A; Goktepeli M; Taydas O; Sayar I
MAGMA; 2022 Jun; 35(3):441-447. PubMed ID: 34727247
[TBL] [Abstract] [Full Text] [Related]
9. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.
Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF
Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019
[TBL] [Abstract] [Full Text] [Related]
10. Return to Work and Employment Situation of Young Adult Cancer Survivors: Results from the Adolescent and Young Adult-Leipzig Study.
Leuteritz K; Friedrich M; Sender A; Richter D; Mehnert-Theuerkauf A; Sauter S; Geue K
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):226-233. PubMed ID: 32746763
[No Abstract] [Full Text] [Related]
11. MicroRNA expression in relation with clinical evolution of osteosarcoma.
Monterde-Cruz L; Ramírez-Salazar EG; Rico-Martínez G; Linares-González LM; Guzmán-González R; Delgado-Cedillo E; Estrada-Villaseñor E; Valdés-Flores M; Velázquez-Cruz R; Hidalgo-Bravo A
Pathol Res Pract; 2020 Aug; 216(8):153038. PubMed ID: 32703501
[TBL] [Abstract] [Full Text] [Related]
12. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
Namazov A; Gemer O; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Lavie O; Amit A; Levy T; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Ben-Arie A
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():120-124. PubMed ID: 31689674
[TBL] [Abstract] [Full Text] [Related]
13. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract] [Full Text] [Related]
14. Radiation-associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma.
Salminen SH; Sampo MM; Böhling TO; Tuomikoski L; Tarkkanen M; Blomqvist CP
Cancer Med; 2018 Sep; 7(9):4825-4835. PubMed ID: 30044058
[TBL] [Abstract] [Full Text] [Related]
15. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract] [Full Text] [Related]
16. Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.
Ross DS; Giri DD; Akram MM; Catalano JP; Olcese C; Van Zee KJ; Brogi E
Breast J; 2017 Mar; 23(2):182-192. PubMed ID: 28299887
[TBL] [Abstract] [Full Text] [Related]
17. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential diagnosis to Atypically Presenting Osteosarcoma.
Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
[TBL] [Abstract] [Full Text] [Related]
18. High-grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging.
Lou S; Balluff B; de Graaff MA; Cleven AH; Briaire-de Bruijn I; Bovée JV; McDonnell LA
Proteomics; 2016 Jun; 16(11-12):1802-13. PubMed ID: 27174013
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.
Schulten HJ; Al-Mansouri Z; Baghallab I; Bagatian N; Subhi O; Karim S; Al-Aradati H; Al-Mutawa A; Johary A; Meccawy AA; Al-Ghamdi K; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S7. PubMed ID: 25923053
[TBL] [Abstract] [Full Text] [Related]
20. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract] [Full Text] [Related]
[Next]
